AIDS and Behavior

, Volume 17, Supplement 1, pp 60–69 | Cite as

Assessing Priorities for Combination HIV Prevention Research for Men Who have Sex with Men (MSM) in Africa

  • Stefan Baral
  • Andrew Scheibe
  • Patrick Sullivan
  • Gift Trapence
  • Andrew Lambert
  • Linda-Gail Bekker
  • Chris Beyrer
Original Paper

Abstract

A consultation was hosted in South Africa (March 2011) to assess the combination HIV prevention research priorities of academics, implementers and MSM community leaders. Sixty-nine participants, representing 17 African countries, participated. Interactive strategies were used to present current data on HIV interventions and discussions on research possibilities were facilitated with research priorities identified using the nominal group technique. Data were analysed using directed content analysis. Health worker training, social mobilisation, and community engagement were prioritised as structural interventions. Comprehensive counselling was identified as the most important behavioural intervention, with adherence, mental health, and risk reduction counselling identified as key counselling topics. Rectal microbicides, oral pre-exposure prophylaxis and condom and lubricant distribution were the most important biomedical interventions. This consultation resulted in the first combination HIV prevention research agenda for MSM in Africa. Outcomes will inform future research and be used to advocate for combination approaches to HIV prevention for MSM.

Keywords

Combination HIV prevention MSM Africa 

Resumen

Una consulta se celebró en Sudáfrica en marzo de 2011 para evaluar las prioridades de investigación de prevención de VIH de combinación de académicos, entidades ejecutoras y líderes de la comunidad MSM. Los participantes de sesenta y nueve, que representan a 17 países africanos, participaron. Se utilizaron estrategias interactivas para presentar datos actuales sobre las intervenciones de VIH y discusiones sobre las posibilidades de investigación se vio facilitados con las prioridades de investigación identificadas mediante la técnica de grupo nominal. Los datos se analizaron mediante análisis de contenido dirigido. Formación de los trabajadores sanitarios, movilización social y participación de la Comunidad fueron priorizadas como las intervenciones estructurales. Asesoramiento integral fue identificada como la más importante intervención conductual, con adherencia, salud mental y reducción de riesgo asesoramiento identificado como clave de asesoramiento temas. Microbicidas rectales, profilaxis pre-exposición oral y preservativo y distribución de lubricante compatibles con preservativos fueron las más importantes intervenciones biomédicas. Esta consulta dio lugar a la primera combinación del programa de investigación de prevención de VIH para MSM en África. Resultados informarán a futuras investigaciones y utilizados para promover la enfoques de combinación para la prevención del VIH para MSM.

Notes

Acknowledgment

The funding for this consultation was provided by a grant to the Johns Hopkins Fogarty AIDS International Training Research Program (Grant# 2 D 43 TW000010-23-AITRP). The funder played no role in the content of this manuscript or the decision to publish these results.

References

  1. 1.
    Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet. 2009;374(9687):416–22.PubMedCrossRefGoogle Scholar
  2. 2.
    Baral S, Trapence G, Motimedi F, Umar E, Iipinge S, Dausab F, et al. HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS ONE. 2009;4(3):e4997.PubMedCrossRefGoogle Scholar
  3. 3.
    Beyrer C, Wirtz AL, Walker D, Johns B, Sifakis F, Baral SD. The Global HIV epidemics among men who have sex with men. Washington, DC: The World Bank; 2011.Google Scholar
  4. 4.
    Beyrer C, Baral SD, Walker D, Wirtz AL, Johns B, Sifakis F. The expanding epidemics of HIV type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency. Epidemiol Rev. 2010;32(1):137–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Poteat T, Diouf D, Drame FM, Ndaw M, Traore C, Dhaliwal M, et al. HIV risk among MSM in Senegal: a qualitative rapid assessment of the impact of enforcing laws that criminalize same sex practices. PLoS ONE. 2011;6(12):e28760.PubMedCrossRefGoogle Scholar
  6. 6.
    amfAR, International AIDS Vaccine Initiative, Johns Hopkins University—Center for Public Health and Human Rights, United Nationals Development Programme. Respect protect fulfil. New York: amfAR; 2012.Google Scholar
  7. 7.
    Merson MH, O’Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet. 2008;372(9637):475–88.PubMedCrossRefGoogle Scholar
  8. 8.
    Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen M, Chen Y, McCauley M, Gambel T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRefGoogle Scholar
  11. 11.
    Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. New York: Science; 2010;329(5996):1168–74.Google Scholar
  12. 12.
    Thigpen M, Kebaabetswe P, Smith D, Segolodi T, Soud F, Chillag K, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. In: 6th IAS Conference on HIV Pathogenesis, treatment and prevention, Rome; 2011.Google Scholar
  13. 13.
    Baeten J, Celum C. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual african men and women: the partners PrEP study. In: 6th IAS conference on HIV pathogenesis, treatment and prevention, Rome; 2011.Google Scholar
  14. 14.
    Liebert MA. Early end for FEM-PrEP HIV prevention trial. AIDS patient care STDs. 2011;25(6):383.CrossRefGoogle Scholar
  15. 15.
    Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010;5(4):298–304.PubMedCrossRefGoogle Scholar
  17. 17.
    Dalton P, McCord A. HIV sexual transmission under HAART: project inform comments on 2008 Swiss statement. Proj Inf Perspect [Newspaper Article]. 2008;Sept(46):26–8.Google Scholar
  18. 18.
    Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis. 2011;204(12):1918–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, Berry N, et al. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med. 2008;5(8):e157.PubMedCrossRefGoogle Scholar
  20. 20.
    McGowan I. Rectal microbicides: can we make them and will people use them? AIDS behav. 2011;15(Suppl 1):S66–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Herbst JH, Sherba RT, Crepaz N, Deluca JB, Zohrabyan L, Stall RD, et al. Meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005;39(2):228–41.PubMedGoogle Scholar
  22. 22.
    Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane database of systematic reviews (Online). 2008;(3):CD001230.Google Scholar
  23. 23.
    Stephenson R, Rentsch C, Sullivan P. High levels of acceptability of couples-based HIV testing among MSM in South Africa. AIDS care. 2012;24(4):529–35.PubMedGoogle Scholar
  24. 24.
    Sullivan PS, Stephenson R, Salazar L, Mann M, Scales L, Allen S. Prevalence of serodiscordance, seropositivity, and exclusionary factors in US male couples presenting for couples voluntary counseling and testing (CVCT): preliminary results. In: 6th IAS conference on HIV pathogenesis, treatment and prevention, Rome; 2011.Google Scholar
  25. 25.
    Golden MR, Stekler J, Hughes JP, Wood RW. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr. 2008;49(2):212–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRefGoogle Scholar
  27. 27.
    Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285–301.PubMedCrossRefGoogle Scholar
  28. 28.
    Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008;372(9640):764–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S132–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Burks DJ. Lesbian, gay, and bisexual victimization in the military: an unintended consequence of “Don’t Ask, Don’t Tell”? Am Psychol. 2011;66(7):604–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Bhardwaj K, Divan V. Sexual health and human rights. A legal and jurisprudential review of select countries in the SEARO region: Bagladesh, India, Indonesia, Nepal, Sri Lanka and Thailand. Report. Geneva: WHO; 2011.Google Scholar
  32. 32.
    Wilson E, Pant SB, Comfort M, Ekstrand M. Stigma and HIV risk among Metis in Nepal. Cult Health Sex. 2011;13(3):253–66.PubMedCrossRefGoogle Scholar
  33. 33.
    Pulerwitz J, Barker G. Measuring attitudes toward gender norms among young men in Brazil development and psychometric evaluation of the GEM scale. Men Masculinities. 2008;10(3):322–38.CrossRefGoogle Scholar
  34. 34.
    Fay H, Baral SD, Trapence G, Motimedi F, Umar E, Iipinge S, et al. Stigma, health care access, and HIV knowledge among men who have sex with men in Malawi, Namibia, and Botswana. AIDS Behav. 2011;15(6):1088–97.PubMedCrossRefGoogle Scholar
  35. 35.
    Baral S, Burrell E, Scheibe A, Brown B, Beyrer C, Bekker L-G. HIV risk and associations of HIV Infection among men who have sex with men in Peri-Urban Cape Town, South Africa. BMC Public Health. 2011;11(1):766.PubMedCrossRefGoogle Scholar
  36. 36.
    Baral S, Adams D, Lebona J, Kaibe B, Letsie P, Tshehlo R, et al. A cross-sectional assessment of population demographics, HIV risks and human rights contexts among men who have sex with men in Lesotho. J Int AIDS Soc. 2011;14(1):36.PubMedCrossRefGoogle Scholar
  37. 37.
    Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep. 2011;8(1):62–72.PubMedCrossRefGoogle Scholar
  38. 38.
    Padian NS, McCoy SI, Manian S, Wilson D, Schwartländer B, Bertozzi SM. Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr. 2011;58(2):e23–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Merson M, Padian N, Coates TJ, Gupta GR, Bertozzi SM, Piot P, et al. Combination HIV prevention. Lancet. 2008;372(9652):1805–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Rispel LC. a. Breaking the silence: South African HIV policies and the needs of men who have sex with men. Reprod Health Matters. 2009;17(33):133–42.PubMedCrossRefGoogle Scholar
  41. 41.
    Beyrer C, Baral S, Kerrigan D, El-Bassel N, Bekker L-G, Celentano DD. Expanding the space: inclusion of most-at-risk populations in HIV prevention, treatment, and care services. J Acquir Immune Defic Syndr. 2011;57(Suppl 2):S96–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(8 Suppl 2):II2–45.PubMedGoogle Scholar
  43. 43.
    Scheibe A, Duby Z, Brown B, Sanders EJ, Bekker L-G. Evaluation of a health care worker training program around sensitization around men who have sex with men (MSM) in Cape Town, South Africa. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2011;CDD132.Google Scholar
  44. 44.
    Wiysonge CS, Kongnyuy EJ, Shey M, Muula AS, Navti OB, Akl EA, et al. Male circumcision for prevention of homosexual acquisition of HIV in men. Cochrane Database Systematic Reviews (Online). 2011;(6):CD007496.Google Scholar
  45. 45.
    Sánchez J, Sal Y, Rosas VG, Hughes JP, Baeten JM, Fuchs J, Buchbinder SP, et al. Male circumcision and risk of HIV acquisition among men who have sex with men from the United States and Peru. AIDS. 2011;25(4):519–23.PubMedCrossRefGoogle Scholar
  46. 46.
    Beyrer C, Trapence G, Motimedi F, Umar E, Iipinge S, Dausab F, et al. Bisexual concurrency, bisexual partnerships, and HIV among Southern African men who have sex with men. Sex Transm Infect. 2010;86(4):323–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Johnson WD, Holtgrave DR, McClellan WM, Flanders WD, Hill AN, Goodman M. HIV intervention research for men who have sex with men: a 7-year update. AIDS Educ Prev. 2005;17(6):568–89.PubMedCrossRefGoogle Scholar
  48. 48.
    Padian NS, Holmes CB, Mccoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President’ s emergency plan for AIDS relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56(3):199–203.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Stefan Baral
    • 1
    • 5
  • Andrew Scheibe
    • 2
  • Patrick Sullivan
    • 3
  • Gift Trapence
    • 4
  • Andrew Lambert
    • 2
  • Linda-Gail Bekker
    • 2
    • 6
  • Chris Beyrer
    • 1
    • 5
  1. 1.Department of EpidemiologyJohns Hopkins School of Public HealthBaltimoreUSA
  2. 2.Desmond Tutu HIV Foundation, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health SciencesUniversity of Cape TownCape TownSouth Africa
  3. 3.Department of EpidemiologyEmory UniversityAtlantaUSA
  4. 4.Center for Development of People (CEDEP)LilongweMalawi
  5. 5.Center for Public Health and Human RightsJohns Hopkins School of Public HealthBaltimoreUSA
  6. 6.Department of Medicine, Institute of Infectious Disease and Molecular MedicineUniversity of Cape TownCape TownSouth Africa

Personalised recommendations